These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38837390)

  • 1. Mapping the Pharmacogenetic Landscape in a Ugandan Population: Implications for Personalized Medicine in an Underrepresented Population.
    Samarasinghe SR; Lee SB; Corpas M; Fatumo S; Guchelaar HJ; Nagaraj SH
    Clin Pharmacol Ther; 2024 Oct; 116(4):980-995. PubMed ID: 38837390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of the PGx-Passport: A Panel of Actionable Germline Genetic Variants for Pre-Emptive Pharmacogenetic Testing.
    van der Wouden CH; van Rhenen MH; Jama WOM; Ingelman-Sundberg M; Lauschke VM; Konta L; Schwab M; Swen JJ; Guchelaar HJ
    Clin Pharmacol Ther; 2019 Oct; 106(4):866-873. PubMed ID: 31038729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetic analysis of structural variation in the 1000 genomes project using whole genome sequences.
    Sherman CA; Claw KG; Lee SB
    Sci Rep; 2024 Oct; 14(1):22774. PubMed ID: 39354004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comprehensive Thai pharmacogenomics database (TPGxD-1): Phenotype prediction and variants identification in 942 whole-genome sequencing data.
    John S; Klumsathian S; Own-Eium P; Eu-Ahsunthornwattana J; Sura T; Dejsuphong D; Sritara P; Vathesatogkit P; Thongchompoo N; Thabthimthong W; Teerakulkittipong N; Chantratita W; Sukasem C
    Clin Transl Sci; 2024 Jun; 17(6):e13830. PubMed ID: 38853370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of pharmacogenetic variants from large scale next generation sequencing data in the Saudi population.
    Goljan E; Abouelhoda M; ElKalioby MM; Jabaan A; Alghithi N; Meyer BF; Monies D
    PLoS One; 2022; 17(1):e0263137. PubMed ID: 35089958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interethnic Variability in CYP2D6, CYP2C9, and CYP2C19 Genes and Predicted Drug Metabolism Phenotypes Among 6060 Ibero- and Native Americans: RIBEF-CEIBA Consortium Report on Population Pharmacogenomics.
    Naranjo MG; Rodrigues-Soares F; Peñas-Lledó EM; Tarazona-Santos E; Fariñas H; Rodeiro I; Terán E; Grazina M; Moya GE; López-López M; Sarmiento AP; Calzadilla LR; Ramírez-Roa R; Ortiz-López R; Estévez-Carrizo FE; Sosa-Macías M; Barrantes R; LLerena A;
    OMICS; 2018 Sep; 22(9):575-588. PubMed ID: 30183544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An analysis of allele, genotype and phenotype frequencies, actionable pharmacogenomic (PGx) variants and phenoconversion in 5408 Australian patients genotyped for CYP2D6, CYP2C19, CYP2C9 and VKORC1 genes.
    Mostafa S; Kirkpatrick CMJ; Byron K; Sheffield L
    J Neural Transm (Vienna); 2019 Jan; 126(1):5-18. PubMed ID: 30191366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tribal ethnicity and CYP2B6 genetics in Ugandan and Zimbabwean populations in the UK: implications for efavirenz dosing in HIV infection.
    Jamshidi Y; Moreton M; McKeown DA; Andrews S; Nithiyananthan T; Tinworth L; Holt DW; Sadiq ST
    J Antimicrob Chemother; 2010 Dec; 65(12):2614-9. PubMed ID: 20952418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacogenomic landscape of an Indigenous Australian population.
    Samarasinghe SR; Hoy W; Jadhao S; McMorran BJ; Guchelaar HJ; Nagaraj SH
    Front Pharmacol; 2023; 14():1180640. PubMed ID: 37284308
    [No Abstract]   [Full Text] [Related]  

  • 10. Phenotype prediction and characterization of 25 pharmacogenes in Thais from whole genome sequencing for clinical implementation.
    Mauleekoonphairoj J; Chamnanphon M; Khongphatthanayothin A; Sutjaporn B; Wandee P; Poovorawan Y; Nademanee K; Pongpanich M; Chariyavilaskul P
    Sci Rep; 2020 Nov; 10(1):18969. PubMed ID: 33144648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Actionable pharmacogenetic variants in Hong Kong Chinese exome sequencing data and projected prescription impact in the Hong Kong population.
    Yu MHC; Chan MCY; Chung CCY; Li AWT; Yip CYW; Mak CCY; Chau JFT; Lee M; Fung JLF; Tsang MHY; Chan JCK; Wong WHS; Yang J; Chui WCM; Chung PHY; Yang W; Lee SL; Chan GCF; Tam PKH; Lau YL; Tang CSM; Yeung KS; Chung BHY
    PLoS Genet; 2021 Feb; 17(2):e1009323. PubMed ID: 33600428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of CYP2B6 and CYP2A6 Pharmacogenetic Variation in Sub-Saharan African Populations.
    Twesigomwe D; Drögemöller BI; Wright GEB; Adebamowo C; Agongo G; Boua PR; Matshaba M; Paximadis M; Ramsay M; Simo G; Simuunza MC; Tiemessen CT; Lombard Z; Hazelhurst S
    Clin Pharmacol Ther; 2024 Mar; 115(3):576-594. PubMed ID: 38049200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of pharmacogenomic variants affecting safety and efficacy of immunomodulators and biologics in a South Asian population from Sri Lanka.
    Ranasinghe P; Liyanage C; Sirisena N; Liyanage S; Priyadarshani CDN; Hendalage DPB; Dissanayake VHW
    Hum Genomics; 2024 Sep; 18(1):107. PubMed ID: 39334333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preemptive Pharmacogenomic Testing for Precision Medicine: A Comprehensive Analysis of Five Actionable Pharmacogenomic Genes Using Next-Generation DNA Sequencing and a Customized CYP2D6 Genotyping Cascade.
    Ji Y; Skierka JM; Blommel JH; Moore BE; VanCuyk DL; Bruflat JK; Peterson LM; Veldhuizen TL; Fadra N; Peterson SE; Lagerstedt SA; Train LJ; Baudhuin LM; Klee EW; Ferber MJ; Bielinski SJ; Caraballo PJ; Weinshilboum RM; Black JL
    J Mol Diagn; 2016 May; 18(3):438-445. PubMed ID: 26947514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of CYP2D6 Pharmacogenetic Variation in Sub-Saharan African Populations.
    Twesigomwe D; Drögemöller BI; Wright GEB; Adebamowo C; Agongo G; Boua PR; Matshaba M; Paximadis M; Ramsay M; Simo G; Simuunza MC; Tiemessen CT; Lombard Z; Hazelhurst S
    Clin Pharmacol Ther; 2023 Mar; 113(3):643-659. PubMed ID: 36111505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinically actionable genotypes for anticancer prescribing among >1500 patients with pharmacogenomic testing.
    Reizine NM; Danahey K; Truong TM; George D; House LK; Karrison TG; van Wijk XMR; Yeo KJ; Ratain MJ; O'Donnell PH
    Cancer; 2022 Apr; 128(8):1649-1657. PubMed ID: 35090043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotypic and phenotypic landscapes of 51 pharmacogenes derived from whole-genome sequencing in a Thai population.
    Wankaew N; Chariyavilaskul P; Chamnanphon M; Assawapitaksakul A; Chetruengchai W; Pongpanich M; Shotelersuk V
    PLoS One; 2022; 17(2):e0263621. PubMed ID: 35176049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of pharmacogenetic variation in nine biogeographic groups.
    Hernandez S; Hindorff LA; Morales J; Ramos EM; Manolio TA
    Clin Transl Sci; 2024 Sep; 17(9):e70017. PubMed ID: 39206687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repurposing of Diagnostic Whole Exome Sequencing Data of 1,583 Individuals for Clinical Pharmacogenetics.
    van der Lee M; Allard WG; Bollen S; Santen GWE; Ruivenkamp CAL; Hoffer MJV; Kriek M; Guchelaar HJ; Anvar SY; Swen JJ
    Clin Pharmacol Ther; 2020 Mar; 107(3):617-627. PubMed ID: 31594036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analytical Validation of a Computational Method for Pharmacogenetic Genotyping from Clinical Whole Exome Sequencing.
    Ly RC; Shugg T; Ratcliff R; Osei W; Lynnes TC; Pratt VM; Schneider BP; Radovich M; Bray SM; Salisbury BA; Parikh B; Sahinalp SC; Numanagić I; Skaar TC
    J Mol Diagn; 2022 Jun; 24(6):576-585. PubMed ID: 35452844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.